Market Overview

Mettler-Toledo International Inc. Announces Webcast of Presentation at J.P. Morgan Healthcare Conference


COLUMBUS, Ohio - December 28, 2012 - Mettler-Toledo International Inc. (NYSE: MTD) today announced the webcast of its presentation at the J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 8, 2013, at 3:30 p.m. Pacific Time (6:30 p.m. Eastern Time).  To hear a live webcast of the presentation, visit the investor relations page on the Company's Web site at www.mt.com/investors.  A replay of the webcast will be available for seven days. 

METTLER TOLEDO is a leading global supplier of precision instruments and services.  The Company has strong leadership positions in all businesses and believes it holds global number-one market positions in a majority of them.  Specifically, METTLER TOLEDO is the largest provider of weighing instruments for use in laboratory, industrial and food retailing applications.  The Company is also a leading provider in analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development and process analytics instruments used for in-line measurement in production processes.  In addition, METTLER TOLEDO is the largest supplier of end-of-line inspection systems used in production and packaging for food, pharmaceutical and other industries.  Additional information about METTLER TOLEDO can be found at "www.mt.com/investors."

Contact: Mary T. Finnegan, Treasurer / Investor Relations, +1-614-438-4748







This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Mettler-Toledo International Inc. via Thomson Reuters ONE

HUG#1667565

 

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters